Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Current Assets (2016 - 2025)

Bioceres Crop Solutions' Current Assets history spans 7 years, with the latest figure at $408.7 million for Q2 2024.

  • For Q2 2024, Current Assets rose 2.91% year-over-year to $408.7 million; the TTM value through Jun 2024 reached $408.7 million, up 2.91%, while the annual FY2024 figure was $408.7 million, 2.91% up from the prior year.
  • Current Assets for Q2 2024 was $408.7 million at Bioceres Crop Solutions, up from $397.1 million in the prior quarter.
  • Across five years, Current Assets topped out at $408.7 million in Q2 2024 and bottomed at $164.7 million in Q2 2020.
  • The 4-year median for Current Assets is $304.3 million (2021), against an average of $295.5 million.
  • The largest annual shift saw Current Assets soared 67.7% in 2020 before it grew 2.91% in 2024.
  • A 4-year view of Current Assets shows it stood at $164.7 million in 2020, then grew by 28.41% to $211.5 million in 2021, then skyrocketed by 87.77% to $397.1 million in 2023, then grew by 2.91% to $408.7 million in 2024.
  • Per Business Quant, the three most recent readings for BIOX's Current Assets are $408.7 million (Q2 2024), $397.1 million (Q2 2023), and $211.5 million (Q2 2021).